Cloud Banner

Healthcare

Image

Global Cancer Tumor Profiling Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Cancer Tumor Profiling Market, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer), Biomarker Type (Genomic Biomarker and Protein Biomarker), Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, and Others), Technique (Genomics, Proteomics, Metabolomics, and Epigenetics), Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment, and Monitoring) – Industry Trends and Forecast to 2030.

Cancer Tumor Profiling Market

Cancer Tumor Profiling Market Analysis and Size

Cancer tumor profiling is increasingly being used in Western economies owing to the rising prevalence of cancer all around the world. Cancer is the second leading cause of death all around the world. 1 out of 6 deaths globally is due to cancer. 70% of deaths occur as a result of cancer in the middle class and low class economies. This has widened the scope of growth for the market.                                

Data Bridge Market Research analyses that the global cancer tumor profiling market which was USD 9,543.13 million in 2022, is expected to reach USD 26,840.23 million by 2030, and is expected to undergo a CAGR of 12.5% during the forecast period of 2023 to 2030. “Breast Cancer” dominates the cancer type segment of the global cancer tumor profiling market due to the rising demand for cancer tumor profiling. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer), Biomarker Type (Genomic Biomarker and Protein Biomarker), Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, and Others), Technique (Genomics, Proteomics, Metabolomics, and Epigenetics), Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Illumina, Inc. (U.S.), QIAGEN (Germany), NeoGenomics Laboratories, Inc. (U.S.), HTG Molecular Diagnostics, Inc. (U.S.), Genomic Health Inc. (U.S.), Caris Life Sciences (U.S.), Helomics Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Sysmex Corporation (Japan), Ribomed Biotechnologies, Inc. (U.S.), Guardant Health, Inc. (U.S.), Foundation Medicine (U.S.) Roche Diagnostics (Switzerland), (U.S.), GenScript Biotech Corporation (China), Tempus Labs (U.S.), Boreal Genomics Inc (Canada), Perthera (U.S.), Agendia (U.S.), Omniseq (U.S.) and Histogene X (Belgium)

Market Opportunities

  • Precision Medicine Advancements
  • Companion Diagnostics Development
  • Clinical Trial Advancements

Market Definition

Cancer tumor profiling is a diagnostic procedure or diagnostic test that is conducted to analyze the genetic information of tumor cells in the body. These diagnostic tests are useful in determining the stage of cancer, determining the correct course of action and predicting the recurrence of the tumor.

Global Cancer Tumor Profiling Market Dynamics

Drivers

  • Rising Prevalence of Cancer

The surging prevalence of cancer all around the globe is one of the major factors responsible for fostering the growth of the market. The growing adoption of cancer profiling methods by oncologists in developing economies is carving the way for the growth of the market. According to a 2021 report by the World Health Organisation, cancer was responsible for 13.6 million deaths globally.

  • Research and Development Proficiencies

Rising expenditure for research and development proficiencies, especially in the developed and developing economies pertaining to medical instruments and devices, will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the integration of advanced technologies in healthcare facilities and to enhance the overall course of diagnosis and treatment of cancer is also bolstering the market growth rate.

  • Government Investments in Healthcare Infrastructure

The increase in funding by the federal government is set to drive the market growth rate. Moreover, the growth and expansion of the healthcare industry being driven by both public and private players, especially in developing economies, will create lucrative market growth opportunities. Also, high return on investments assured by the research activities and increasing technological advancements in the field of cancer/tumor profiling will also work in the favour of the market. Additionally, an increase in the utilization of cancer biomarkers for diagnosing cancer/tumor, a surge in the personal disposable income level, the introduction of technologically driven products in hospitals, increasing investment for the development of advanced medical products and devices, a rise in need for point-of-care diagnostics and surging demand for personalized medicines among people, positively affect the market growth rate.

Opportunities

  • Precision Medicine Advancements

The shift towards precision medicine in oncology is a key opportunity for the cancer tumor profiling market. Tumor profiling enables the personalization of cancer treatments based on an individual's unique genetic and molecular profile, leading to more effective therapies and better patient outcomes.

  • Companion Diagnostics Development

The development of companion diagnostics that are closely tied to specific targeted therapies creates opportunities for tumor profiling. Profiling assists in identifying patients who are most likely to respond to these therapies.

Restraints/Challenges

  • Cost and Reimbursement Challenges

The high cost of tumor profiling and associated diagnostic tests can be a significant restraint in the adoption of these services. Tumor profiling involves sophisticated and often expensive techniques, such as NGS and mass spectrometry. Moreover, the interpretation of the data obtained from these tests requires specialized skills. In many cases, the costs are not fully covered by health insurance, and patients may face significant out-of-pocket expenses. The lack of reimbursement or insurance coverage for profiling services can limit accessibility for a portion of the patient population.

  • Data Privacy and Security Concerns

The extensive collection and storage of genetic and molecular data from tumor profiling raise significant data privacy and security concerns. Protecting patient privacy and ensuring compliance with data protection regulations (such as HIPAA in the United States and GDPR in the European Union) is a complex challenge. It involves secure data storage, transmission, and sharing practices, as well as educating healthcare professionals on ethical data handling.

This global cancer tumor profiling market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cancer tumor profiling market. Contact Data Bridge Market Research for an Analyst Brief, and our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In May 2021, NeoGenomics Laboratories collaborated with QIAGEN to offer a companion diagnostic test for HR+/HER2 for advanced breast cancer patients to detect PIK3CA mutation using QIAGEN’s therascreen PIK3CA RGQ PCR test

Global Cancer Tumor Profiling Market Scope

The global cancer tumor profiling market is segmented on the basis of cancer type, biomarker type, technology, technique, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Cancer type

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Other Cancer

Biomarker type

  • Genomic Biomarker
  • Protein Biomarker

Technology

  • Immunoassays
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Mass Spectrometry
  • In-Situ Hybridization
  • Microarrays
  • Others

Technique

  • Genomics
  • Proteomics
  • Metabolomics
  • Epigenetics

Application

  • Research
  • Biomarker Discovery
  • Personalized Medicine
  • Clinical Application
  • Diagnostics
  • Prognostics
  • Screening
  • Treatment and Monitoring

Global Cancer Tumor Profiling Market Regional Analysis/Insights

The global cancer tumor profiling market is analysed, and market size insights and trends are provided by country, cancer type, biomarker type, technology, technique, and application, as referenced above.

The countries covered in the global cancer tumor profiling market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.

North America is expected to dominate the global cancer tumor profiling market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030 due to the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.

Asia-Pacific, on the other hand, is expected to dominate and exhibit the highest growth rate in the global cancer tumor profiling market during the forecast period of 2023 to 2030, owing to the increasing government expenditure on the healthcare sector and rising technological advancements and initiatives by the government.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global cancer tumor profiling market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the global cancer tumor profiling market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global cancer tumor profiling market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Cancer Tumor Profiling Market Share Analysis

The global cancer tumor profiling market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cancer tumor profiling market.

Some of the major players operating in the global cancer tumor profiling market are:

  • Illumina, Inc. (U.S.)
  • QIAGEN (Germany)
  • NeoGenomics Laboratories, Inc. (U.S.)
  • HTG Molecular Diagnostics, Inc. (U.S.)
  • Genomic Health Inc. (U.S.)
  • Caris Life Sciences (U.S.)
  • Helomics Corporation (U.S.)
  • NanoString Technologies, Inc. (U.S.)
  • Sysmex Corporation (Japan)
  • Ribomed Biotechnologies, Inc. (U.S.)
  • Guardant Health, Inc. (U.S.)
  • Foundation Medicine (U.S.)
  • Roche Diagnostics (Switzerland)
  • GenScript Biotech Corporation (China)
  • Tempus Labs (U.S.)
  • Boreal Genomics Inc (Canada)
  • Perthera (U.S.)
  • Agendia (U.S.)
  • Omniseq (U.S.)
  • Histogene X (Belgium)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The cancer tumor profiling market will be worth USD 26,840.23 million by 2030 during the forecast period.
The cancer tumor profiling market growth rate is 12.5% during the forecast period.
Rising prevalence of cancer, government investments in healthcare infrastructure and research and development proficiencies are the growth drivers of the cancer tumor profiling market.
The cancer type, biomarker type, technology, technique, and application are the factors on which the cancer tumor profiling market research is based.
The latest development in the cancer tumor profiling market are NeoGenomics Laboratories collaborated with QIAGEN to offer a companion diagnostic test for HR+/HER2 for advanced breast cancer patients to detect PIK3CA mutation using QIAGEN’s therascreen PIK3CA RGQ PCR test.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials